Trials / Sponsors / Morten Mau-Sørensen
Morten Mau-Sørensen
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Trastuzumab and Standard Treatment With Chemo- and Immunotherapy as First Line Treatment for HER2 Positive Eso Esophageal Squamous Cell Carcinoma, HER-2 Protein Overexpression, HER-2 Gene Amplification | Phase 2 | 2022-02-04 |